# Cocoon Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cocoon-biotech

- Industry: Biotechnology
- Headquarters: US
- Website: www.cocoonbiotech.com
- Latest round: Seed (Jan 10, 2019)
- Investors on record: 1

## About

Founded in 2013 and based in Massachusetts, US, Cocoon Biotech, Inc. operates as a sustainable technology company specializing in the use of silk fibroin to create environmentally friendly and safe products for healthcare, consumer, and industrial applications. The company was founded by its CEO, Ailis Tweed-Kent.

The company's core product, silk fibroin, is a biodegradable protein derived from silkworm cocoons. It offers an alternative to petroleum-derived ingredients commonly used in various products. Cocoon™ utilizes this silk fibroin to formulate a wide range of all-natural personal care products, including sunscreen, moisturizing lotion, anti-aging serum, insect repellent, and hand sanitizer. In addition to consumer products, silk fibroin is also used in pharmaceutical and medical device formulations, enhancing cell proliferation, and promoting healing. Cocoon™ has engineered an adaptable and sustainable natural material, combining expertise in biotechnology, medicine, materials science, and green product design.

## Funding rounds

- Seed, Jan 10, 2019 — Argonautic Ventures

## Investors

- Argonautic Ventures (https://capitalatlas.ai/funds/argonautic-ventures) — Seed